Filters & Sort
  1. Home/
  2. Gwq Serviceplus Ag/
  3. Active Tenders
Reset All
Gwq Serviceplus Ag
Tenders of Gwq Serviceplus Ag

Tenders of Gwq Serviceplus Ag

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Closing Date10 Nov 2025
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Mebeverin

Gwq Serviceplus Ag Tender

Germany
Closing Date10 May 2026
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Codein In Der Darreichungsform Tei

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Closing Date10 May 2026
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Ranibizumab

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Closing Date10 Nov 2025
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Fampridin N3

Gwq Serviceplus Ag Tender

Electrical and Electronics
Germany
Closing Date10 May 2025
Tender AmountRefer Documents 
Germany-düsseldorf: Pharmaceutical Products

Gwq Serviceplus Ag Tender

Germany
Closing Date11 Aug 2025
Tender AmountRefer Documents 
Germany-düsseldorf: Pharmaceutical Products

Gwq Serviceplus Ag Tender

Germany
Closing Date11 Aug 2025
Tender AmountRefer Documents 
Germany-düsseldorf: Pharmaceutical Products

Gwq Serviceplus Ag Tender

Others
Germany
Closing Date10 Nov 2026
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Mit Dem Wirkstoff Doxylamin 6,96 Mg / Pyridoxin 8,23 Mg Hvw (cariban)

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Closing Date11 Aug 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements according to § 130a paragraph 8 Sgb V for the active ingredient glecaprevir | Pibrentasvir

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Closing Date10 May 2025
Tender AmountRefer Documents 
Order announcement - Conclusion of non-exclusive discount agreements according to Section 130 A Paragraph 8 Sgb V for medicinal products with the active ingredient fluticasone + azelastine (nas, Atc code R01ad58)
31-40 of 186 active Tenders
Combined ShapeCreated with Sketch.Sign In
TENDER BY COUNTRIES
View All
United States Tenders|
United Kingdom Tenders|
Spain Tenders|
France Tenders|
Qatar Tenders|
Australia Tenders|
Canada Tenders|
China Tenders|
Malaysia Tenders|
Maldives Tenders|
Singapore Tenders|
Bangladesh Tenders|
Ethiopia Tenders|
Bhutan Tenders|
Kuwait Tenders|
Oman Tenders|
Germany Tenders|
Egypt Tenders|
Ghana Tenders|
Saudi Arabia Tenders
TENDER BY AUTHORITIES
View All
Federal Road Agency Tenders|
Bangladesh Railway Tenders|
Area Metropolitana De Barcelona Tenders|
Jsc Russian Railways Tenders|
Kuwait Oil Company Tenders|
Civil Aviation Authority Tenders|
Food And Agriculture Org. Tenders|
Eskom Tenders|
Energy Regulation Commision Tenders|
Dept Of Defence Tenders
TENDER BY CATEGORIES
View All
Agriculture Or Forestry Works Tenders|
Automobiles And Auto Parts Tenders|
Civil And Construction Tenders|
Consultancy Services Tenders|
Education And Training Services Tenders|
Electrical And Electronics Tenders|
Finance And Insurance Sectors Tenders|
Food Products Tenders|
Furnitures And Fixtures Tenders|
Healthcare And Medicine Tenders
TENDER BY PROCUREMENT
Goods Tenders|
Works Tenders|
Services Tenders
OFG MANUFACTURING BUSINESSES PRIVATE LIMITED
  • Head Office
    6th Floor, Global Business Park, Tower A, Besides Guru Dronacharya Metro Station, Gurugram, Haryana - 122002, India
  • Sales Office
    B - 705 & 706, Sankalp Iconic Tower, Opp. Vikramnagar Colony, Iscon Cross Road, S. G. Highway, Ahmedabad - 380054, India
COMPANY
POLICIES
SUPPORT
MOBILE APPS
© Powered by OFG MANUFACTURING BUSINESSES PRIVATE LIMITED, All Rights Reserved